Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Epilepsy | 2 |
| Mental Retardation | 2 |
| Seizures | 2 |
| Adults | 1 |
| Animals | 1 |
| Brain Hemisphere Functions | 1 |
| Control Groups | 1 |
| Disabilities | 1 |
| Drug Therapy | 1 |
| Drug Use | 1 |
| Followup Studies | 1 |
| More ▼ | |
Source
| American Journal on Mental… | 1 |
| Brain | 1 |
Author
| Holmes, Gregory L. | 2 |
| Lenck-Santini, Pierre-Pascal | 1 |
| Lucas, Marcella M. | 1 |
| Scott, Rod C. | 1 |
Publication Type
| Journal Articles | 2 |
| Opinion Papers | 1 |
| Reports - Research | 1 |
Education Level
Audience
| Researchers | 1 |
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkLucas, Marcella M.; Lenck-Santini, Pierre-Pascal; Holmes, Gregory L.; Scott, Rod C. – Brain, 2011
One of the most common and serious co-morbidities in patients with epilepsy is cognitive impairment. While early-life seizures are considered a major cause for cognitive impairment, it is not known whether it is the seizures, the underlying neurological substrate or a combination that has the largest impact on eventual learning and memory. Teasing…
Descriptors: Animals, Epilepsy, Mental Retardation, Seizures
Holmes, Gregory L.; And Others – American Journal on Mental Retardation, 1989
Five responses to Alvarez (EC 220 238) comment on discontinuation of antiepileptic drugs with mentally retarded patients. (DB)
Descriptors: Adults, Drug Therapy, Epilepsy, Followup Studies
